gen-1
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02480374)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gen-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06915025 | Phase 3 | Jul 9, 2025 | Celsion, Washington University in St. Louis |
| NCT03393884 | Phase 1/Phase 2 (Phase 2) | Sep 5, 2018 | Celsion, Washington University in St. Louis |
| NCT02480374 | Phase 1 | Sep 1, 2015 | Celsion, Washington University in St. Louis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celsion | For profit | 3 | 3 | 3 | 2015 |
| Washington University in St. Louis | Academic/Hospital | 3 | 0 | 3 | 2015 |
2 organizations
Page 1 / 1